Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A consistent bedtime routine can further enhance its benefits
Lancet Diabetes & Endocrinology, 2025 Heart & blood markers Blood pressure and blood-fat readings, tracked as extra measurements across the Phase 2 trials
In company-funded studies, participants taking Wegovy had average weight loss of 15%, about 34 pounds (15.3 kilograms)
Sanyal, MD, Professor of Medicine, Physiology, and Molecular Pathology and Interim-Chair of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, discussed results from a substudy of the obesity trial that looked at patients who also had non-alcoholic fatty liver disease (NAFLD)
Consultation with a healthcare professional is crucial to determine the suitability of tirzepatide as a treatment option and to ensure the best possible outcomes for patients managing diabetes
